Hodgkin's disease: prognostic factors and short-course regimens.

N. L. Bartlett, S. M. Arackal

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Both topics discussed in this review, prognostic factors and short-course regimens for Hodgkin's disease, have been the focus of recent research with the goal of developing tools and treatments that will result in the highest cure rates with the least long-term sequelae. A new "prognostic score" for advanced-stage Hodgkin's disease and several potential prognostic factors, including soluble CD30, soluble interleukin-2 receptor, activated cytotoxic T-lymphocytes, and Epstein-Barr virus, are discussed. Preliminary reports of short-course chemotherapy regimens with and without radiotherapy for all stages of Hodgkin's disease are summarized.

Original languageEnglish
Pages (from-to)163-171
Number of pages9
JournalCurrent oncology reports
Issue number2
StatePublished - Mar 2000


Dive into the research topics of 'Hodgkin's disease: prognostic factors and short-course regimens.'. Together they form a unique fingerprint.

Cite this